Overview News Presentations & Events Analyst Coverage Stock Information SEC Documents Corporate Governance Email Alerts

News

All 2003 Releases
Ligand, TAP Agree to Extend R&D Collaboration to Discover and Develop Novel SARM Drugs
Dec 22, 2003
Clinical Data Presented at ASA Demonstrate that AVINZA(R) Once-Daily Provides
Oct 14, 2003
Ligand and Cambrex Complete New Five-Year Agreement to Manufacture Ligand's Cancer Drug ONTAK(R) and Second-Generation Product
Oct 13, 2003
Ligand Earns Milestone as Wyeth Advances NSP-989
Oct 13, 2003
Ligand and Cambrex Complete New Five-Year Agreement to Manufacture Ligand's Cancer Drug ONTAK(R) and Second-Generation Product
Oct 13, 2003
Ligand Presentation at UBS Warburg Global Life Sciences Conference to be Web Cast September 22
Sep 17, 2003
Ligand Presentation at Roth Capital Partners Conference to be Web Cast September 9
Sep 5, 2003
Ligand and Cambrex Complete New 5-Year Agreement to Manufacture Ligand's Cancer Drug ONTAK(R) and Second-Generation Product
Sep 1, 2003
Ligand Presentation at NewsMakers in the Biotech Industry Conference to be Web Cast September 4
Aug 29, 2003
Ligand Presentation at BIO Annual Convention to be Web Cast June 23
Jun 19, 2003
Ligand Presentation at Goldman Sachs Healthcare Conference to be Web Cast June 12
Jun 9, 2003
Ligand Earns $1 Million Milestone Payment as GlaxoSmithKline Advances Development of 501516
Jun 4, 2003
Ligand Earns $1 Million Milestone Payment as<br> GlaxoSmithKline Advances Development of 501516
Jun 4, 2003
Ligand Presentations at UBS Warburg and Needham Investment Conferences to be Web Cast June 4 and 5
Jun 2, 2003
Ligand's ONTAK Demonstrates Activity Against Chronic Lymphocytic Leukemia, Phase II Study Presented at ASCO Shows
Jun 2, 2003
Ligand's ONTAK Shows Potential to Treat B- and T-Cell Non-Hodgkin's Lymphoma, Phase II Study Presented at ASCO Demonstrates
Jun 2, 2003
Ligand Announces Organizational Changes to Accelerate Operational Improvements
May 15, 2003
Ligand, Lilly Agree to Second Extension of R&D Collaboration to Discover and Develop Novel Drugs for Metabolic Diseases
May 8, 2003
Organon, Ligand Confirm Full, On-Schedule Start of AVINZA(R) Co-Promotion
Apr 9, 2003
Four Clinical Trials Presented at AAD Show Ligand's Targretin, Panretin<br> Demonstrate Promising Activity in Range of Dermatologic Disorders
Mar 24, 2003
Showing 1-20 of 29 Page: 1 2  Next 20